Congress at a Glance
Scientific Programme
Satellite Programme
Maps of the Venue
Search in:
 Papers, Programme or All
 Please use only plain characters
 (e.g., e, o, c and not è, ö or ç)
 		 
   
  Author   or    Free text  
   
  Author list  

  Personal Planner:
  Create a new login and password click here
Nb. Only your Personal Planner login is valid!
  Username Password  
   
 
  


Track:
  Treatment track
  Clinical research track
  Interface track
  Preclinical track
  Educational updates track

 
Scientific Programme Track:
View last minute changes Last minute changes
Back to overview
12:00-14:00 , Sunday, 31 August 2008
Poster session page: 1 2   

12:00-14:00
P.1.a:  Basic and clinical neuroscience - Genetics and genomics
Poster area

P.1.a.001  Apolipoprotein E and cyclooxygenase 2 -765 G>C polymorphisms in Alzheimer’s dementia  Paper: P.1.a.001
A. Juhasz*, A. Rimanoczy, A. Feher, J. Kalman, Z. Janka, Hungary
 

P.1.a.002  Glial cell–derived neurotrophic family (GFR) alpha 1 receptor polymorphisms and weight change during clozapine treatment  Paper: P.1.a.002
R. Souza*, M.A. Romano-Silva, J.A. Lieberman, H.Y. Meltzer, J. Culotti, J.L. Kennedy, A.H.C. Wong, Canada
 

P.1.a.003  Neonatal behavioral characteristics and gene polymorphisms of serotonin 2a, 2c, 6 receptors and serotonin transporter  Paper: P.1.a.003
H.C. Kim*, S.M. Kim, D.K. Kim, Y.N. Park, South-Korea
 

P.1.a.004  Chromosomal aberrations in an African schizophrenia population  Paper: P.1.a.004
L. Koen*, D.J.H. Niehaus, G. De Jong, R.A. Emsley, South Africa
 

P.1.a.005  Differences in TP53 and APC gene polymorphisms between Korean schizophrenia and colon cancer patients  Paper: P.1.a.005
S.H.K. Kim*, D.H.C. Cho, D.S.L. Lee, C.J.K. Kang, J.H.K. Kim, D.K.L. Lee, B.M.C. Choe, C.K.K. Kim, South-Korea
 

View last minute changes
P.1.a.006  Serotonin transporter: an example of gene influence on human behaviour  Paper: P.1.a.006
R. Calati*, D. De Ronchi, A. Serretti, Italy
R. Calati* will be replaced by A. Serretti
 

P.1.a.007  A genetic assessment of antipsychotic and antidepressant cardiac iatrogenicity: focus on the proarrhythmic profile  Paper: P.1.a.007
A. Drago*, F. De Ponti, G. Boriani, D. De Ronchi, A. Serretti, Italy
 

P.1.a.008  Changed expression of RGS4 in pathophysiology of schizophrenia  Paper: P.1.a.008
M. Vrajova*, S. Pekova, J. Horacek, Czech Republic
 

P.1.a.009  CYP2D6 polymorphism in patients with Alzheimer’s disease in treatment with cholinesterase inhibitors  Paper: P.1.a.009
M. Fontana, R. Squitti, C. Bonvicini, L. Benussi, L. Bocchio Chiavetto, M. Ventriglia*, Italy
 

P.1.a.010  Prevalence and MAO gene polymorphism of restless legs syndrome in Korean women  Paper: P.1.a.010
Y.M. Park*, S.H. Lee, Y.C. Chung, H.J. Lee, S.G. Kang, L. Kim, South-Korea
 

P.1.a.011  Effect of angiotension-converting enzyme gene i/d polymorphism on training- and detraining-induced changes in adiposity  Paper: P.1.a.011
J.S. Yi*, H.S. Lee, South-Korea
 

P.1.a.012  Interaction between brain-derived neurotrophic factor Val66Met polymorphism and negative life stressor on harm avoidance  Paper: P.1.a.012
S.J. Kim*, S.J. Cho, H.J. Lee, South-Korea
 

P.1.a.013  The association of BDNF gene val66met polymorphism with the serum BDNF levels in drug-free depressed patients  Paper: P.1.a.013
E. Ozan*, A.S. Gonul, H. Okur, N. Akarsu, C. Eker, O.D. Eker, B. Yulug, N. Aydin, I. Kirpinar, Turkey
 

P.1.a.014  Dopamine D2 receptor gene polymorphisms and tardive dyskinesia in schizophrenia patients  Paper: P.1.a.014
H.J. Lee*, S.G. Kang, C.H. Cho, J.E. Choi, L. Kim, South-Korea
 

P.1.a.015  Polymorphisms of tyrosine hydroxylase and tryptophan hydroxylase genes and clinical phenotypes in schizophrenia  Paper: P.1.a.015
J.W. Kim*, J. Park, J. Song, A. Cho, J. Chung, South-Korea
 

P.1.a.016  GABAergic control of stress-responsive epigenetic and gene expression mechanisms in the dentate gyrus  Paper: P.1.a.016
A. Papadopoulos*, Y. Chandramohan, A. Collins, S.K. Droste, D.J. Nutt, J.M.H.M. Reul, United Kingdom
 

P.1.a.017  Gender could modulate 5-HTTLPR association with antidepressant efficacy in major depression  Paper: P.1.a.017
F. Gressier*, C. Verstuyft, E. Bouaziz, P. Hardy, L. Becquemont, E. Corruble, France
 

P.1.a.018  The influence of 5-HTT, DRD2, DAT1 and NET genes on personality traits is modified by gene – environment interaction  Paper: P.1.a.018
A. Kazantseva*, D. Gaysina, E. Khusnutdinova, Russia
 

P.1.a.019  AKT1 gene single nucleotide polymorphism in Korean patients of schizophrenia and bipolar disorder  Paper: P.1.a.019
E.J. Kim*, K.Y. Lee, South-Korea
 

P.1.a.020  Association study of polymorphisms in GABA and glycine transporter gene with schizophrenia in the Korean population  Paper: P.1.a.020
J.W. Kim*, S. Lee, J. Song, J. Park, A. Cho, J. Chung, South-Korea
 

P.1.a.021  Association of GRIK4 and HTR2A genes with antidepressant treatment in the MARS cohort of depressed inpatients  Paper: P.1.a.021
S. Horstmann*, S. Lucae, A. Menke, M. Ising, B. Müller-Myhsok, F. Holsboer, E. Binder, Germany
 

P.1.a.022  Association study of four polymorphisms of Brain-Derived Neurotrophic Factor (BDNF) gene with schizophrenia  Paper: P.1.a.022
M. Skibinska*, P. Kapelski, A. Slopien, A. Leszczynska-Rodziewicz, B. Godlewska, M. Wilkosc, M. Tomaszewska, M. Dmitrzak-Weglarz, P. Czerski, Poland
 

P.1.a.023  No association between dopamine receptor D4 521 c/t gene polymorphism and bipolar disorder and it subtypes  Paper: P.1.a.023
A. Rajewska-Rager*, A. Leszczynska-Rodziewicz, M. Dmitrzak-Weglarz, M. Skibinska, J.K. Rybakowski, J. Hauser, Poland
 

P.1.a.024  The s allele of the 5-HTTLPR: a possible genetic correlate of traits associated with neuroticism  Paper: P.1.a.024
X. Gonda*, K.N. Fountoulakis, J. Lazary, Z. Rihmer, H.S. Akiskal, G. Bagdy, USA
 

P.1.a.301  Clinical variables, HLA-DQB1*0602 allele and hypocretin in narcolepsy with cataplexy
S. Lee, J.H. Jeong*, S.C. Hong, Y.K. Shin, J.H. Han, South-Korea
 

P.1.a.302  Association study of single nucleotide polymorphisms on COMT gene in Korean schizophrenics
Dong Ki Lee*, South-Korea
 

P.1.a.303  Ethnicity and psychotropic medications: Homer genes structure analysis of HapMap database
V. De Luca*, A. de Bartolomeis, G. Muscettola, Italy
 

12:00-14:00
P.1.b:  Basic and clinical neuroscience - Neuroanatomy and neurophysiology
Poster area

P.1.b.001  Clinical characteristics and heart rate variability in patients comorbid panic disorder with major depressive disorder  Paper: P.1.b.001
Y. Choi*, M.S. Kim, South-Korea
 

P.1.b.002  Detrended fluctuation analysis of heart rate variability in obstructive sleep apnea  Paper: P.1.b.002
C.J. Shin*, D.H. Park, South-Korea
 

P.1.b.003  Supervised machine learning algorithms predict “correct” classification of retinal ganglia neuron subtypes  Paper: P.1.b.003
S. Matthews*, H. Jelinek, C.S. McLachlan, I. Spence, Australia
 

P.1.b.004  Activation of thalamo-cortical circuits by phencyclidine, reversal by clozapine  Paper: P.1.b.004
N. Santana*, P. Celada, G. Mengod, F. Artigas, Spain
 

P.1.b.005  Auditory and visual event-related potential P300 as a “trait” and a “state” markers in patients with schizophrenia  Paper: P.1.b.005
Y. Jeon*, J. Yi, E. Park, South-Korea
 

P.1.b.006  Nasal cycle difference in schizophrenia: can it reflect the cerebral lateralization abnormality?  Paper: P.1.b.006
D. Senol, E. Ozan*, S. Tanisman, N. Aydin, I. Kirpinar, Turkey
 

P.1.b.301  Case report: magnetic resonance imaging finding: subcortical band heterotopia
O. Karamustafalioglu, Y. Cengiz Ceylan*, C.Guner, S. Gonenli, B. Goksan, B. Bakim, Turkey
 

12:00-14:00
P.1.c:  Basic and clinical neuroscience - Neuropharmacology
Poster area

P.1.c.001  An ethopharmacological assessment of the effects of (R,S)-2-chloro-5-hydroxyphenylglycine (CHPG) on agonistic interactions in male mice  Paper: P.1.c.001
P. Huertas*, M. Martín-López, E. Burón, J.F. Navarro, Spain
 

P.1.c.002  Effects of tramadol on cardiac-related modulation of dorso-medial medullar neural activity under pain influence  Paper: P.1.c.002
H. Prudnikau*, V. Soltanov, V. Leschenko, P. Pivchenko, H. Prudnikava, Belarus
 

P.1.c.003  Chronic paroxetine and alprazolam decrease the hypothalamic activity in rodents threatened by venomous coral snake  Paper: P.1.c.003
T. Paschoalin-Maurin, N.C. Coimbra*, Brazil
 

P.1.c.004  Acute paroxetine or alprazolam attenuate defensive responses of hamsters confronted with venomous coral snake  Paper: P.1.c.004
T. Paschoalin-Maurin, N.C. Coimbra*, Brazil
 

P.1.c.005  Role of 5-HT2A/2C serotonergic receptors in the anterior pretectal nucleus electric stimulation-induced antinociception  Paper: P.1.c.005
A.D. Carvalho*, N.C. Coimbra, Brazil
 

P.1.c.006  Involvement of A2A receptors in anxiolytic, locomotor and motivational’s properties of ethanol in mice  Paper: P.1.c.006
H. Houchi*, V. Warnault, E. Barbier, C. Dubois, O. Pierrefiche, M. Daoust, M. Naassila, France
 

P.1.c.007  Serotonin pathway genes polymorphisms and the clinical response to citalopram among children and adolescents  Paper: P.1.c.007
B. Rotberg*, S. Kronenberg, M. Carmel, A. Frisch, D. Brent, N. Melhem, G. Zalsman, A. Apter, A. Weizman, Israel
 

P.1.c.008  Is a dual mechanism of action better than a single one in the inhibition of nociception by antidepressants ?  Paper: P.1.c.008
R. Suciu*, M. Ardelean, Romania
 

P.1.c.009  Enhanced expression of glutathione S-transferase in the brain of mice treated with trimethyltin  Paper: P.1.c.009
R. Nagashima*, S. Sano, H. Han, K. Ogita, Japan
 

P.1.c.010  Glycine-sensitive NMDA receptors positively regulate proliferative activity in neural progenitor cells  Paper: P.1.c.010
K. Ogita*, Y. Gotoh, M. Yoneyama, Japan
 

P.1.c.011  Reactive oxygen species positively regulate proliferative activity in neural progenitor cells  Paper: P.1.c.011
M. Yoneyama*, K. Kawada, K. Ogita, Japan
 

P.1.c.012  Modulators of inhibitory synaptic transmission in mouse somatosensory cortex  Paper: P.1.c.012
I. Kruglikov*, B. Rudy, USA
 

P.1.c.013  Some molecular aspects of haloperidol's neurotoxicity  Paper: P.1.c.013
E. Zhuravliova*, T. Barbakadze, N. Natsvlishvili, D. Mikeladze, Georgia
 

P.1.c.014  Recruitment of a bicarbonate transporter in the modulation of glutamatergic transmission in hippocampus  Paper: P.1.c.014
N. Fedirko*, M. Chesler, USA
 

P.1.c.015  1-Methyl-1,2,3,4-tetrahydroisoquinoline antagonizes behavioral and neurochemical effects produced by MK-801 in rat  Paper: P.1.c.015
L. Antkiewicz-Michaluk*, I. Romanska, J. Michaluk, Poland
 

P.1.c.016  Metabolic profile of eslicarbazepine acetate in mice and the role of liver in the systemic drug exposure  Paper: P.1.c.016
G. Alves*, A. Falcão, I. Figueiredo, M. Castel-Branco, M. Caramona, P. Soares-da-Silva, Portugal
 

P.1.c.017  Relationship between plasma and brain pharmacokinetic profiles of eslicarbazepine acetate metabolites in mice  Paper: P.1.c.017
G. Alves*, A. Falcão, I. Figueiredo, M. Castel-Branco, M. Caramona, P. Soares-da-Silva, Portugal
 

P.1.c.018  ß1-adrenergic receptor activation evokes a long-lasting increase in hippocampal theta (4-15Hz) rhythm in vitro  Paper: P.1.c.018
D. Haggerty*, M.A. Whittington, F.E.N. LeBeau, United Kingdom
 

P.1.c.019  Regulation of pro-apoptotic Fas/FADD protein complex in brain regions of CB1-receptor deficent mice  Paper: P.1.c.019
M. Álvaro-Bartolomé*, S. Esteban, O. Valverde, J.A. García-Sevilla, Spain
 

P.1.c.020  Chronic treatment with imidazoline I2-drugs down-regulates key proteins of the canonical apoptotic pathways in rat brain  Paper: P.1.c.020
C. Garau*, A. Miralles, J.A. García-Sevilla, Spain
 

View last minute changes
P.1.c.021  Amitriptyline does not potentiate the anti-hyperalgesic effects of gabapentin in a model of painful diabetic neuropathy  Paper: P.1.c.021
R. Stepanovic Petrovic*, M. Tomic, S. Vuckovic, M. Prostran, B. Boskovic, Serbia
Withdrawn
 

P.1.c.022  Pharmacological characterization of ghrelin receptor in rat adenoma anterior pituitary cell line, RC-4B/C  Paper: P.1.c.022
E. Perdona*, F. Faggioni, C. Corti, C. Cavanni, Italy
 

P.1.c.023  Neuroendocrine effects and safety of intravenously administered desmopressin in healthy volunteers  Paper: P.1.c.023
G. Jacobs*, E.G.J. Hulskotte, H.H. Zuurman, J. Burggraaf, J. Elassais-Schaap, P.A.M. Peeters, J.M.A. van Gerven, G. Ruigt, The Netherlands
 

P.1.c.024  Intra-basolateral amygdala nitric oxide inhibitor prevents prepulse inhibition disruption induced by dopamine agonists  Paper: P.1.c.024
C. Salum*, A.C. Issy, M.L. Brandao, F.S. Guimaraes, E.A. Del Bel, Brazil
 

View last minute changes
P.1.c.025  Effect of amlodipine on the biphasic modulation of seizure threshold by morphine  Paper: P.1.c.025
T. Gholipour*, S. Farough, K. Riazi, A.R. Noorian, A. Jannati, A.R. Dehpour, Iran
Withdrawn
 

P.1.c.026  Effect of mood stabilizers on the Akt/GSK-3ß signaling pathway and on cell survival and proliferation.  Paper: P.1.c.026
J.M. Aubry*, M. Schwald, E. Ballmann, F. Karege, Switzerland
 

P.1.c.027  Peroxisome proliferator-activated receptors (PPARs): new target for attention and memory function  Paper: P.1.c.027
C. Mazzola*, L.V. Panlilio, S.R. Goldberg, S. Yasar, F. Drago, Italy
 

P.1.c.028  Long-acting injectable form of antipsychotic drug risperidone based upon microspheres of polyhydroxyalkanoates  Paper: P.1.c.028
A.P. Bonartsev*, A.L. Iordanskii, G.A. Bonartseva, O.S. Brusov, Russia
 

P.1.c.029  Experimental research on the effects of dopaminergic receptor antagonists in cutaneous and visceral pain models  Paper: P.1.c.029
I. Sacara*, A. Hristov, L. Tartau, Romania
 

P.1.c.030  Proteomic analysis or rat brain after treatment with risperidone  Paper: P.1.c.030
B.C. Kim*, C.S. Lee, C.S. Park, J.W. Sohn, Y.H. Jin, South-Korea
 

P.1.c.031  Lower thalamic myo-inositol level in schizophrenic patients with better cognitive outcome  Paper: P.1.c.031
A. Szulc*, B. Galinska, E. Tarasow, W. Dzienis, B. Kubas, B. Konarzewska, R. Poplawska, A. Czernikiewicz, J. Walecki, Poland
 

P.1.c.032  Mice deficient of prodynorphin show increased vulnerability to anxietylike behaviours and reduced response to bromazepam  Paper: P.1.c.032
T. Femenía Cantó*, J. Manzanares, Spain
 

P.1.c.033  Milnacipran reduces stress-induced ultrasonic vocalisations in rats, without impairing attention in the 5-choice serial reaction time test  Paper: P.1.c.033
L. Bardin*, A. Auclair, A. Newman-Tancredi, R. Depoortere, France
 

P.1.c.034  Postsynaptic 5-HT1A receptors are involved in the excitatory action of 8-OH-DPAT on prefrontal cortex pyramidal neurons  Paper: P.1.c.034
L. Lladó-Pelfort*, F. Artigas, P. Celada, Spain
 

P.1.c.035  The role of nitric oxide in PC12 cells death. Protective effect of 12-lipoxygenase and cyclooxygenases inhibitors  Paper: P.1.c.035
M. Pytlowany*, M. Cakala, P.R. Strosznajder, H. Jesko, J.B. Strosznajder, Poland
 

P.1.c.036  Anxiolytic-like effects induced by acute reversible inactivation of the bed nucleus of stria terminalis  Paper: P.1.c.036
L.B.M. Resstel*, F.H.F. Alves, D.G. Reis, C.C. Crestani, F.M.A. Corrêa, F.S. Guimarães, Brazil
 

P.1.c.037  Surinabant inhibits the effects of delta 9-tetrahydrocannabinol in a novel tetrahydrocannabinol-challenge test  Paper: P.1.c.037
L. Klumpers*, C. Roy, F. Poitiers, S. Turpault, J.M.A. van Gerven, The Netherlands
 

P.1.c.038  The role of substance-P in control of aggressive behavior: possible implications for treating violent psychopathologies  Paper: P.1.c.038
M. Toth*, J. Halasz, E. Mikics, B. Barsvari, A. Tulogdi, J. Haller, Hungary
 

P.1.c.039  Concomitant blockade of 5-HT1a receptor and 5-HT transporter: use of Hunter serotonin toxicity criteria in a clinical pharmacology study  Paper: P.1.c.039
V. Parks*, S. Chalon, S. Raje, A. Plotka, A. Philip, N. Olivier, USA
 

P.1.c.040  MDMA induces oxytocin release in humans  Paper: P.1.c.040
G. Dumont*, F.C.G.J. Sweep, R. van der Steen, R. Hermsen, D.J. Touw, J.K. Buitelaar, R.J. Verkes, The Netherlands
 

P.1.c.041  Manganese influence on morphine-induced conditioned place preference in rats  Paper: P.1.c.041
D. Ciubotariu*, I. Chelarescu, B. Stoica, M. Nechifor, Romania
 

P.1.c.042  D3 receptor involvement in neurotrophic effects of amphetamine and cocaine on mesencephalic dopaminergic neurons  Paper: P.1.c.042
G. Collo*, A. Gregorini, C. Missale, P.F. Spano, Italy
 

P.1.c.043  Involvement of glutamate neurotransmission in the activation of midbrain dopamine neurones by 5-HT1A receptor agonists  Paper: P.1.c.043
C. Liauzun, B. Gronier*, United Kingdom
 

P.1.c.044  Effects of acute flibanserin on FDG-PET brain glucose metabolism in men with major depressive disorder  Paper: P.1.c.044
J.Z. Konarski, R. Pyke, G. Wunderlich, S.H. Kennedy*, Canada
 

P.1.c.045  Modulation of hippocampal gamma (30-80 Hz) frequency oscillations in vitro by serotonin  Paper: P.1.c.045
D.C. Eden*, M.A. Whittington, C. Racca, F.E.N. LeBeau, United Kingdom
 

P.1.c.046  Tianeptine attenuates the staurosporine- and doxorubicin- induced apoptosis in primary cortical neurons  Paper: P.1.c.046
D. Jantas*, W. Lason, Poland
 

P.1.c.047  F15599, a post-synaptic cortical preferential 5-HT1A agonist: III) electrophysiology and microdialysis  Paper: P.1.c.047
L. Lladó-Pelfort*, M.B. Assié, P. Celada, A. Newman-Tancredi, F. Artigas, Spain
 

P.1.c.048  Nitric oxide modulate methylphenidate-induced disruption on prepulse inhibition of the acoustic startle in swiss mice  Paper: P.1.c.048
A.C. Issy*, C. Salum, E.A. Del Bel, Brazil
 

P.1.c.049  Alertness and electrocortical activity after (co-)administration of MDMA and THC in healthy volunteers  Paper: P.1.c.049
M.M. Lansbergen*, G.J.H. Dumont, J.K. Buitelaar, J.M.A. van Gerven, R.J. Verkes, The Netherlands
 

View last minute changes
P.1.c.050  The rise and fall of salivary alpha amylase: effects of drugs and stress  Paper: P.1.c.050
A. Van Stegeren*, O. Wolf, Germany
Withdrawn
 

P.1.c.051  Effects of lamotrigine, topiramate and riluzole exerted upon pilocarpine-induced seizures in rodents  Paper: P.1.c.051
W.A. Turski*, M. Czuczwar, J. Kis, D. Nieoczym, W. Zgrajka, W. Brzana, P. Wlaz, Poland
 

P.1.c.301  Prenatal administration of analog of AVP(6-9) analog Ac-D-MPRG influences on the postpound behaviour in white rats
O. Voskresenskaya*, V. Golubovich, A.Kamensky, Russia
 

P.1.c.302  Preliminary researches on the effects of some serotonine re-uptake inhibitors in a visceral pain model
I. Sacara*, A. Hristov, L.Tartau, Romania
 

P.1.c.303  Does L-glutamate toxicity differ with the duration of neuronal culture?
A. Tatar*, A. Hacimuftuoglu, U.Ozgen, H. Suleyman, Z. Halici, E. Ozan, Turkey
 

P.1.c.304  Postponed effects of neonatal chronical arginine-vasopressin structural analogue administration
P.A. Kim*, O.G. Voskresenskaya, A.A.Kamensky, Russia
 

P.1.c.305  Stress-like effects of corticotropin-releasing factor fragment CRF4-6
E. Makarenko*, D.V. Tsvirkun, A.A. Martyanov, Russia
 

P.1.c.306  Effects of ACTH(4-10) analogue semax prenatal administration and prenatal stress on white rats behavior
M. Volodina*, E.A. Sebentsova, N.G. Levitskaya, L.A. Andreeva, A.A. Kamensky, Russia
 

P.1.c.307  Influence of afobazole on infarct size and passive avoidance learning after local ischemia
K. Ashrafyan*, M. Balasanyan, A. Mkhitaryan, Rep. of Armenia
 

12:00-14:00
P.1.d:  Basic and clinical neuroscience - Animal models
Poster area

P.1.d.001  A selective mglu1 receptor antagonist, jnj16259685, suppresses isolation-induced aggression in male mice  Paper: P.1.d.001
V. De Castro*, M.M. Martin-Lopez, J.F. Navarro-Humanes, Spain
 

P.1.d.002  The effect of chlordiazepoxide on reward reduction-induced decrease of operant performance.  Paper: P.1.d.002
A. Nikiforuk*, P. Popik, Poland
 

P.1.d.003  Effects of early maternal separation during the development on the behavioral change in the forced swimming test in rats  Paper: P.1.d.003
Y. Chung*, S.H. Park, Y.M. Lee, B.D. Lee, South-Korea
 

P.1.d.004  Menadione-induced reactive oxygen species generation is intracellular mechanism that promotes cell`s apoptosis  Paper: P.1.d.004
N. Grychan*, A. Kotljarova, S. Kramar, N. Fedirko, Ukraine
 

P.1.d.005  The effects of topiramate on spatial memory and movement co-ordination in rats  Paper: P.1.d.005
E. Nowakowska*, K. Kus, A. Czubak, J. Jedrzejewska, Poland
 

P.1.d.006  Effects of LY379268, a selective agonist of mGlu2/3 receptors, on isolation-induced aggression in male mice  Paper: P.1.d.006
J.F. Navarro, M.J. Luque, V. De Castro*, M. Martín-López, Spain
 

View last minute changes
P.1.d.007  Direct and indirect modulation of cannabinoid system in psychotic-like symptoms and cognitive deficit induced by phencyclidine (PCP)  Paper: P.1.d.007
C. Guidali*, D. Vigano', T. Rubino, D. Parolaro, Italy
Withdrawn
 

P.1.d.008  Environmental enrichment has anxiolytic effect in female C57BL/6, but not in female BALB/c mice  Paper: P.1.d.008
P. Pokk*, K. Õkva, T. Nevalainen, Finland
 

P.1.d.009  Asenapine: a translational analysis of receptor occupancy in human and rat brain with therapeutic implications  Paper: P.1.d.009
B. Henry, S. Grimwood, R. de Greef, M. Shahid*, United Kingdom
 

P.1.d.010  Effects of maternal separation and antidepressant treatment on adult brain and behavior in a rat model of depression  Paper: P.1.d.010
A. El Khoury*, M. Werme, S.H.M. Gruber, A.A. Mathé, Sweden
 

P.1.d.011  Phosphonate analogue of ketoglutarate increases activity of ketoglutarate dehydrogenasecomplex in situ and in vivo  Paper: P.1.d.011
L.K. Trofimova, A.V. Graf*, E.I. Klimuk, M.S. Kabysheva, N.A. Sokolova, V.I. Bunik, Russia
 

P.1.d.012  Comparison of donepezile, ispronicline, varenicline and vinpocetine in two types of learning paradigms in rodents  Paper: P.1.d.012
J. Laszy*, V. Román, A. Szemzo, I. Gyertyán, Hungary
 

P.1.d.013  Microarray analysis of inflammatory gene expressions in the hypothalamus of sleep deprived mice  Paper: P.1.d.013
J.W. Kim*, J. Song, H. Won, J. Chung, South-Korea
 

View last minute changes
P.1.d.014  Neurochemical alterations in an environmental animal model of schizophrenia: strain related differences  Paper: P.1.d.014
S. Castrignano*, M. Colaianna, A. De Giorgi, S. Schiavone, M. Zotti, L. Trabace, Italy
S. Castrignano* will be replaced by L. Trabace
 

P.1.d.015  Behavioral, proliferative and molecular correlations in the rat chronic mild stress model of depression  Paper: P.1.d.015
O. Wiborg*, M.N. Jayatissa, C.F. Bisgaard, T. Christensen, K. Henningsen, A. Bergström, M. Skovgaard Jensen, M.J. West, Denmark
 

View last minute changes
P.1.d.016  Olfactory perception test is necessary in sociobiobehavioral researches  Paper: P.1.d.016
A. Amikishieva*, S. Semendyaeva, Russia
Withdrawn
 

P.1.d.017  Effect of aripiprazole on behaviour and leukocyte phagocytosis in the olfactory bulbectomy model of depression in rats  Paper: P.1.d.017
J. Pistovcakova*, A. Sulcova, Czech Republic
 

P.1.d.018  Quantitative EEG in ketamine model of psychosis  Paper: P.1.d.018
T. Palenicek*, M. Kutova, M. Fujakova, V. Bubenikova-Valesova, M. Brunovsky, M. Horacek, Czech Republic
 

12:00-14:00
P.1.e:  Basic and clinical neuroscience - Brain imaging
Poster area

P.1.e.001  Coexpression of serotonin transporter and serotonin-1A receptor in human brain: a multitracer PET study  Paper: P.1.e.001
M. Savli*, D. Haeusler, A. Holik, M. Fink, A. Hahn, M. Mitterhauser, W. Wadsak, K. Kletter, S. Kasper, R. Lanzenberger, Austria
 

P.1.e.002  A case of transient global amnesia with high signal intensities at the both hippocampi on diffusion-weighted MRI  Paper: P.1.e.002
H.C. Kim*, K.S. Kim, C.H. Sohn, South-Korea
 

P.1.e.003  Regional binding potentials of [11C]mirtazapine enantiomers in human brain  Paper: P.1.e.003
D. Smith*, S.B. Hansen, S. Jakobsen, D. Bender, H. Audrain, M. Askhanian, B.S. Stork, R. Rosenberg, Denmark
 

P.1.e.004  Increased P-glycoprotein function in major depression  Paper: P.1.e.004
O. de Klerk*, A.T.M. Willemsen, F.J. Bosker, J.A. den Boer, The Netherlands
 

View last minute changes
P.1.e.005  Serotonergic genes and amygdala activity in response to negative affective facial stimuli  Paper: P.1.e.005
B. Ham*, B. Lee, South-Korea
Withdrawn
 

View last minute changes
P.1.e.006  Sertraline versus eye movement desensitization and reprocessing (EMDR): effects on hippocampal volumes and PTSD symptoms  Paper: P.1.e.006
M. Tavanti*, L. Bossini, S. Calossi, D. Marino, G. Vatti, R. Galli, F. Pieraccini, P. Castrogiovanni, Italy
M. Tavanti* will be replaced by P. Castrogiovanni
 

P.1.e.007  Effect of sertraline treatment on regional cerebral blood flow in obsessive compulsive disorder  Paper: P.1.e.007
S. Ebrinc*, A. Sahan, U.B. Semiz, C. Basoglu, A. Ates, A. Algul, M. Cetin, Turkey
 

P.1.e.008  Eszopiclone reverses brain hyperarousal in insomnia patients: evidence from [18F]-FDG PET  Paper: P.1.e.008
E. Nofzinger*, D.J. Buysse, D. Moul, M. Hall, A. Germain, J. Price, USA
 

P.1.e.009  Optimized voxel-based morphometry of gray matter volume in major depressive disorder  Paper: P.1.e.009
I.H. Paik*, H.K. Lim, C.U. Lee, C.U. Pae, J.J. Kim, C. Lee, South-Korea
 

P.1.e.010  The investigation of orbitofrontal cortex and amygdala association in depressed patients by structural equation modeling  Paper: P.1.e.010
B. Zengin*, E. Ozan, O. Kitis, C. Eker, O. Eker, A.S. Gonul, Turkey
 

P.1.e.011  Brain correlates of theory of mind in the early course of schizophrenia  Paper: P.1.e.011
R. Herold*, M. Simon, A. Feldmann, T. Tenyi, S. Fekete, Hungary
 

P.1.e.012  Lateralization of serotonin-1A receptor distribution in language areas revealed by positron emission tomography  Paper: P.1.e.012
M. Fink*, M. Savli, P. Stein, A. Hahn, C. Spindelegger, M. Mitterhauser, W. Wadsak, K. Kletter, S. Kasper, R. Lanzenberger, Austria
 

P.1.e.013  In PET test-retest reproducibility of serotonin transporter binding correlates with the regional binding potential  Paper: P.1.e.013
U. Moser*, R. Lanzenberger, D. Haeusler, M. Fink, C. Spindelegger, M. Mitterhauser, W. Wadsak, E. Akimova, K. Kletter, S. Kasper, Austria
 

View last minute changes
P.1.e.014  Mechanism of memory suppression in patients with anxiety disorder: a fMRI study  Paper: P.1.e.014
M. Baiano*, M. Maieron, L. Perini, R. Zuliani, G. Como, N. Agarwal, C. Zuiani, M. Bazzocchi, M. Balestrieri, P. Brambilla, Italy
Withdrawn
 

P.1.e.015  Frontal serotonin-1A receptor distribution is associated with aggression scores in healthy subjects  Paper: P.1.e.015
A.V. Witte*, A. Flöel, P. Stein, M. Savli, A. Hahn, M. Fink, M. Mitterhauser, W. Wadsak, S. Kasper, R. Lanzenberger, Austria
 

P.1.e.016  Anatomical abnormalities of the anterior cingulate cortex before the onset of psychosis  Paper: P.1.e.016
A. Fornito*, A.R. Yung, S.J. Wood, L.J. Phillips, B. Nelson, S. Cotton, D. Velakoulis, P.D. McGorry, C. Pantelis, M. Yücel, United Kingdom
 

P.1.e.017  Hydrocortisone induces limbic, hippocampal and limbic/paralimbic cerebral perfusion changes as measured by 3T blood oxygenation level dependent (BOLD) phMRI  Paper: P.1.e.017
R.J. Tyacke*, R. Holmes A. Reid, E.J. Grant, B. Henry, F. Zelaya, J.M.H.M. Reul, S. Lightman, S.C.R. Williams, D.J. Nutt, A.L. Malizia, United Kingdom
 

P.1.e.018  Hypoperfusion and reduced blood-oxygen level dependent activation of the fusiform face area patients with delusional misidentification syndrome  Paper: P.1.e.018
T. Müller*, A. Federspiel, P. Bianchi, H. Horn, M. Wirth, S. Walther, R. Wiest, W. Strik, Switzerland
 

P.1.e.019  PET-measured occupancy of the norepinephrene transporter by extended release quetiapine fumarate (quetiapine XR) in brains of healthy subjects  Paper: P.1.e.019
S. Nyberg*, A. Takano, A. Jucaite, P. Karlsson, D. McCarthy, M. Kågedal, H. Eriksson, C.M. Lee, C. Halldin, L. Farde, Sweden
 

P.1.e.020  Effects of cannabis ingredients in the temporal cortex- neural basis for potential antipsychotic effect of cannabidiol  Paper: P.1.e.020
S. Bhattacharyya*, P. Fusar-Poli, S. Borgwardt, R. Martin-Santos, C. O'Carroll, M. Seal, J.A. Crippa, Z. Atakan, P.K. McGuire, United Kingdom
 

P.1.e.301  Influence of psychotherapy on the brain of psychiatric patients
M. Diallina, S. Prassas, E. Kalantzi*, D. Georgonikou, Greece
 

12:00-14:00
P.1.f:  Basic and clinical neuroscience - Neurodevelopment
Poster area

P.1.f.001  Developmental vitamin D deficiency in the rat induces a sexually dimorphic delayed onset in sensitivity to MK-801  Paper: P.1.f.001
J. Kesby*, J.C. O'Loan, J.J. McGrath, D.W. Eyles, T.H.J. Burne, Australia
 

P.1.f.002  Mental retardation and history of mental disorders during childhood and adolescence among adults with schizophrenia  Paper: P.1.f.002
M. Negueruela Lopez*, M.M. Perez-Rodriguez, A. Ceverino Domínguez, F.J. Quintero-Gutierrez del Alamo, A. Fernandez del Moral, M.A. Jimenez-Arriero, M. Martinez Vigo, I. Basurte Villamor, J. Sevilla Vicente, E. Baca García, Spain
 

P.1.f.003  Plasma BDNF concentration in somatization disorder and its relation with clinical characteristics  Paper: P.1.f.003
I.K. Hwang*, S.K. Chung, Y.C. Chung, T.W. Park, J.C. Yang, Y.K. Kim, South-Korea
 

View last minute changes
P.1.f.301  New fields of research in forensic psychiatry. Neurophysiological and structural changes in murderers with PTSD
J. Heitzman, A. Silczuk*, Poland
A.Silczuk* will be replaced by J. Heitzman
 

12:00-14:00
P.1.g:  Basic and clinical neuroscience - Cognitive neuroscience
Poster area

P.1.g.001  Are impairments of sleep-dependent memory consolidation in depression related to HPA axis dysfunction?  Paper: P.1.g.001
M. Dresler*, M. Kluge, L. Genzel, P. Schüssler, A. Steiger, Germany
 

P.1.g.002  Aspects of working memory performance in first-episode of schizophrenia patients and healthy siblings  Paper: P.1.g.002
N. Ghirasim*, C. Popescu, I. Miclutia, Romania
 

P.1.g.003  Modafinil and caffeine reversal on daytime sleepiness and cognitive dysfunction induced by sleep deprivation  Paper: P.1.g.003
S.K. Wang*, J.L. Kim, I.S. Chee, M.R. Ku, South-Korea
 

P.1.g.004  Neurocognitive deficit changes in relation to the course of schizophrenia: five-year follow-up study  Paper: P.1.g.004
Y. Zaytseva, Russia
 

P.1.g.005  Improving metabolic health outcomes in mentally ill populations with the Mieux-Être Wellness program  Paper: P.1.g.005
C. Shriqui*, I. Lachance, Mieux-Être Wellness Program Collaborative Group, Canada
 

P.1.g.006  Cognitive disorders in 6-hydroxydopamine-induced rat model of Parkinson’s disease  Paper: P.1.g.006
A. Ciobica*, L. Hritcu, V. Artenie, M. Padurariu, Romania
 

P.1.g.007  Some aspects concerning the interaction between the cholinergic and noradrenergic systems in memory processes in rats  Paper: P.1.g.007
A. Ciobica*, L. Hritcu, V. Artenie, M. Padurariu, Romania
 

P.1.g.008  Association between a cannabinoid receptor gene (CNR1) polymorphism and the auditory event-related P300 potential  Paper: P.1.g.008
P. Roser*, A.M. Stadelmann, L. Arning, J. Gallinat, J.T. Epplen, G. Juckel, Germany
 

P.1.g.009  Attentional bias towards health-threat information in chronic fatigue syndrome  Paper: P.1.g.009
R. Hou*, R. Moss-Morris, B. Bradley, R. Peveler, K. Mogg, United Kingdom
 

P.1.g.010  Oxidative stress damage of hippocampus induced memory impairment in rats  Paper: P.1.g.010
M. Padurariu*, L. Hritcu, A. Ciobica, V. Artenie, Romania
 

View last minute changes
P.1.g.011  Attentional networks in schizophrenia: influence of type of medication and duration of disease  Paper: P.1.g.011
Y. Rabah, O. BenAzouz*, O. Kebir, I. Johnson, L. Dellagi, I. Amado, K. Tabbane, Tunesian Republic
Withdrawn
 

P.1.g.012  The comparison of memory functions in patients with obsessive compulsive disorder and panic disorder  Paper: P.1.g.012
Y. Ceylan Cengiz*, A. Tabo, B. Ozcelik, O. Guclu, M. Yaman, Turkey
 

P.1.g.013  The longitudinal prospective structure of common mental disorders during adolescence and early adulthood  Paper: P.1.g.013
A.T. Gloster*, J. Klotsche, M. Hoefler, K. Beesdo, R. Lieb, H.U. Wittchen, Germany
 

P.1.g.014  The role of the dopamine beta-hydroxylase (DBH) gene in human cognitive function  Paper: P.1.g.014
S. Reppermund*, R. Lieb, A. Heck, A. Ellgas, S. Lucae, F. Holsboer, M. Ising, Germany
 

P.1.g.015  Differential effects of personality trait on facial expression recognition. An repetitive TMS investigation  Paper: P.1.g.015
M. Di Simplicio*, V. Falzarano, A. De Capua, S. Rossi, Italy
 

P.1.g.016  Relative contribution of the alpha2-, 3- and 5-containing GABAA receptors to benzodiazepine effects in the water maze  Paper: P.1.g.016
S. Joksimovic*, M.M. Savic, T. Clayton, S. Huang, S. Ara, M. Van Linn, M.M. Milinkovic, D.R. Bokonjic, W. Sieghart, J.M. Cook, Serbia
 

P.1.g.017  Self-esteem and quality of life in peritoneal dialysis patients  Paper: P.1.g.017
H. Karadag, A. Karaoglan*, A. Oztemel, S. Orsel, H. Turkcapar, Turkey
 

P.1.g.018  Cognitive performance in adolescents with anorexia nervosa: subgroups in relation to neuropsychological impairment  Paper: P.1.g.018
S. Andres Perpiña*, E. Lozano P, O. Puig Navarro, S. Lera Miguel, L. Lazaro Garcia, J. Castro-fornieles, Spain
 

P.1.g.019  RY-023, an inverse agonist at alpha5 GABAA receptors: the influence on spatial memory and spontaneous locomotor activity  Paper: P.1.g.019
M.M. Milinkovic*, M.M. Savic, S. Rallapalli, J. Samardzic, M. Van Linn, N. Ugresic, J.M. Cook, Serbia
 

P.1.g.020  Mental health in inward patients with polycystic ovarian syndrome  Paper: P.1.g.020
M. Musiol*, R. Kowalczyk, V. Skrzypulec, Poland
 

P.1.g.021  Effects of a novel inverse agonist selective for alpha5 GABAA receptors on spatial memory: comparison with the standard non-selective inverse agonist DMCM  Paper: P.1.g.021
J. Samardzic*, M.M. Savic, T. Clayton, S. Rallapalli, D.I. Obradovic, S.M. Joksimovic, W. Sieghart, J.M. Cook, Serbia
 

P.1.g.301  Evaluation of a social skill training in a schizophrenic outpatient’s group
M. Briki*, A. Pahin, P. Vandel, E. Haffen,D. Sechter , France
 

12:00-14:00
P.1.h:  Basic and clinical neuroscience - Epidemiology
Poster area

P.1.h.001  Comorbid patterns of psychiatric disorders in Korean communities  Paper: P.1.h.001
J.H. Sohn, Y.W. Park, S.M. Chang*, B.S. Kim, S.K. Kim, M.J. Cho, South-Korea
 

P.1.h.002  The effects of race and other factors on diagnosis in psychiatric inpatients: a retrospective chart review  Paper: P.1.h.002
M. Choi*, T. Yoo, C. Wood, Y. Yun, USA
 

P.1.h.003  Prevalence and comorbidity of premenstrual dysphoric disorder in Korea  Paper: P.1.h.003
J.P. Hong*, H.S. Kim, S.J. Kim, S.B. Park, M.J. Cho, South-Korea
 

P.1.h.004  Change of mental health status caused by flood in a Korean village: prospective study over an eighteen-month period  Paper: P.1.h.004
S. Min*, J. Heo, S. Go, M. Kim, K. Park, J. Shin, South-Korea
 

12:00-14:00
P.1.i:  Basic and clinical neuroscience - Other
Poster area

P.1.i.001  Chronic citalopram treatment counteracts kainic acid induced increase in PSA-NCAM expressing cells and avoids migration  Paper: P.1.i.001
K. Jaako*, M. Helmdorf, A. Zharkovsky, Estonia
 

View last minute changes
P.1.i.002  Ca2+ buffering by mitochondria - key mechanism for modulation of store-operated Ca2+ entry induced by neurotransmitters  Paper: P.1.i.002
O. Kopach*, I. Kruglikov, N. Voitenko, N. Fedirko, Ukraine
Withdrawn
 

P.1.i.003  Overexpression of Kv2.1 channel in DRG neurons enhances exocytosis independent of its ion-conducting function  Paper: P.1.i.003
D. Chikvashvili*, D. Singer-Lahat, R. Nachman, I. Lotan, Israel
 

P.1.i.004  GABA transporter 1 (GAT1) specifically binds to ubiquitins in the mouse brain  Paper: P.1.i.004
S.K. Lee*, S.H. Park, D. Seog, South-Korea
 

P.1.i.005  Differential BDNF levels in a genetic rat model of depression  Paper: P.1.i.005
P. Plougmann*, G. Wegener, R. Rosenberg, B. Elfving, Denmark
 

P.1.i.006  The effect of ultra-low doses of anti-S100 antibodies on stress-induced increase in c-Fos immunoreactivity in rats  Paper: P.1.i.006
J.L. Dugina*, P.E. Umryukhin, K.V. Sudakov, I.A. Kheifets, S.A. Sergeeva, O.I. Epstein, Russia
 

P.1.i.007  Differential brain, but not serum vascular endothelial growth factor levels in a genetic rat model of depression  Paper: P.1.i.007
B. Elfving*, P.H. Plougmann, R. Rosenberg, G. Wegener, Denmark
 

P.1.i.008  A link between the serotonin transporter and oxytocin  Paper: P.1.i.008
D. Marazziti*, S. Baroni, I. Masala, M. Catena Dell'Osso, G. Giannaccini, L. Betti, C. Carmassi, A. Lucacchini, Italy
 

P.1.i.301  Hyperhomocysteinemia in children’s psychiatric hospital
S. Purvina, L. Kevere*, D. Bauze, M. Zeibarts, A. Rizevs, I. Purvins,M. Caune, R. Andrezina, Latvia
 

12:00-14:00
P.6.a:  Addiction - Alcohol (clinical)
Poster area

P.6.a.001  Personality trait of alcoholic patients using the Korean version of temperament and character inventory  Paper: P.6.a.001
J.S. Lee*, H.K. Kim, E.S. Ahn, H.S. Oh, South-Korea
 

P.6.a.002  Cue-induced activation in alcohol-dependent patients pre and post treatment with and without cue-exposure based training  Paper: P.6.a.002
S. Vollstädt-Klein, S. Löber, R. Stadelmann, C. von der Goltz, K. Mann, F. Kiefer*, Germany
 

View last minute changes
P.6.a.003  Is attentional bias a good measure of incentive properties of alcohol-associated stimuli in alcohol-dependent patients?  Paper: P.6.a.003
S. Loeber*, S. Vollstaedt-Klein, C. von der Goltz, K. Mann, F. Kiefer, Germany
S. Loeber* will be replaced by F. Kiefer
 

View last minute changes
P.6.a.004  The use of sensibilizing medicines in the therapy of alcohol dependence  Paper: P.6.a.004
A. Kozyreva*, Russia
Withdrawn
 

P.6.a.005  Comparative sleep improving effects of zolpidem vs. nitrazepam in alcoholics  Paper: P.6.a.005
M. Jakovcevska-Kujundziska*, V. Lazarova, N. Cadikovska, V. Filovska, Macedonia
 

P.6.a.006  Response inhibition and decision making as predictors for future heavy alcohol use in a prospective study  Paper: P.6.a.006
A.E. Goudriaan*, E.R. Grekin, K.J. Sher, The Netherlands
 

P.6.a.007  Venlafaxine vs. alprazolam in the treatment of alcohol dependence  Paper: P.6.a.007
V. Lazarova*, M. Jakovcevska Kujundziska, N. Cadikovska, V. Filovska, Macedonia
 

P.6.a.008  Personality disorders in patients with alcohol abuse and alcoholism: an exploratory study  Paper: P.6.a.008
K.M. Ivanov, M.G. Alexandrova, R.D. Stoychev, D.K. Kirov, L.Z. Tumbev, K.R. Stoychev*, H.V. Vasilev, K.I. Kukov, Bulgaria
 

P.6.a.009  Pregabalin versus naltrexone in alcohol dependence: results from a multicenter, rondomized, double-blind, comparison trial  Paper: P.6.a.009
G. Martinotti*, M. Di Nicola, D. Tedeschi, R. Guglielmo, L. Janiri, Italy
 

P.6.a.010  Differential effects of stress on alcohol-related behaviours in moderate and heavy social drinkers  Paper: P.6.a.010
J. Nesic*, T. Duka, United Kingdom
 

P.6.a.011  Tiagabine in the treatment of alcoholism: a pilot study  Paper: P.6.a.011
T. Paparrigopoulos, E. Tzavellas*, D. Karaiskos, N. Stefanis, A. Komporozos, I. Mourikis, J. Liappas, Greece
 

P.6.a.012  Alcoholism management in inpatient and outpatient centres in France*  Paper: P.6.a.012
H. Houchi, France
 

P.6.a.013  Error processing in alcohol dependence  Paper: P.6.a.013
A.F.A. Schellekens*, C. van Lankveld, E. de Bruijn, W. Hulstijn, J.K. Buitelaar, C.A.J. de Jong, R.J. Verkes, The Netherlands
 

page: 1 2